{"id":9856,"date":"2025-05-21T01:23:19","date_gmt":"2025-05-20T23:23:19","guid":{"rendered":"https:\/\/aliber.org\/web\/?p=9856"},"modified":"2025-05-21T01:53:36","modified_gmt":"2025-05-20T23:53:36","slug":"aliber-apoya-la-iniciativa-de-rdi-en-la-semana-de-la-asamblea-mundial-de-la-salud-ams-en-ginebra","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2025\/05\/21\/aliber-apoya-la-iniciativa-de-rdi-en-la-semana-de-la-asamblea-mundial-de-la-salud-ams-en-ginebra\/","title":{"rendered":"ALIBER apoya la iniciativa de RDI en la semana de la Asamblea Mundial de la Salud (AMS) en Ginebra."},"content":{"rendered":"<p>Todo apunta a que la Resoluci\u00f3n sobre Enfermedades Raras deber\u00eda adoptarse, pero existe mucha incertidumbre en torno a las implicaciones presupuestarias y los ejercicios presupuestarios de la OMS. Durante los pr\u00f3ximos d\u00edas, el debate probablemente se centrar\u00e1 en cuestiones presupuestarias y financieras, as\u00ed como en la priorizaci\u00f3n de las actividades de la OMS. La incertidumbre general sobre las implicaciones financieras de la adopci\u00f3n de nuevas resoluciones probablemente dominar\u00e1 los debates de la AMS.<\/p>\n<p>Ahora es el momento de que la Coalici\u00f3n participe activamente para promover la adopci\u00f3n de la Resoluci\u00f3n a trav\u00e9s de todos los canales posibles, incluidas las redes sociales. En este orden de ideas, ALIBER muestra su apoyo a la Resoluci\u00f3n y la pertenencia a esta Coalici\u00f3n de m\u00e1s de 270 miembros.<\/p>\n<p>Contamos con todos para garantizar la adopci\u00f3n e implementaci\u00f3n exitosa de la <a href=\"#Resolution4rare\">#Resolution4rare<\/a>.<\/p>\n<p>Tu apoyo para concientizar y promover su adopci\u00f3n es crucial.<\/p>\n<p>\u00a1Gracias a todos!<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-9859 size-full\" src=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1.jpeg\" alt=\"\" width=\"1080\" height=\"1080\" srcset=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1.jpeg 1080w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1-300x300.jpeg 300w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1-1024x1024.jpeg 1024w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1-150x150.jpeg 150w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1-768x768.jpeg 768w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1-250x250.jpeg 250w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1-174x174.jpeg 174w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi1-120x120.jpeg 120w\" sizes=\"(max-width: 1080px) 100vw, 1080px\" \/><\/p>\n<p><img decoding=\"async\" class=\"aligncenter wp-image-9860 size-full\" src=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2.jpeg\" alt=\"\" width=\"1080\" height=\"1080\" srcset=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2.jpeg 1080w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2-300x300.jpeg 300w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2-1024x1024.jpeg 1024w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2-150x150.jpeg 150w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2-768x768.jpeg 768w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2-250x250.jpeg 250w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2-174x174.jpeg 174w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/rdi2-120x120.jpeg 120w\" sizes=\"(max-width: 1080px) 100vw, 1080px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Todo apunta a que la Resoluci\u00f3n sobre Enfermedades Raras deber\u00eda adoptarse, pero existe mucha incertidumbre en torno a las implicaciones presupuestarias y los ejercicios presupuestarios de la OMS. Durante los<a href=\"https:\/\/aliber.org\/web\/2025\/05\/21\/aliber-apoya-la-iniciativa-de-rdi-en-la-semana-de-la-asamblea-mundial-de-la-salud-ams-en-ginebra\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":9860,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[2,8,3,138],"tags":[],"class_list":["post-9856","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aliber","category-encuentros","category-eventos","category-noticias"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=9856"}],"version-history":[{"count":2,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9856\/revisions"}],"predecessor-version":[{"id":9862,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9856\/revisions\/9862"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media\/9860"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=9856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=9856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=9856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}